Cat.#: ACPP-1611
| Despition | ICA69 Human Recombinant |
| SIZE | 100 µg |
| Purity | > 85% by SDS-PAGE. |
| Form | Liquid |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1153 | MERTK Blocking Peptide (AC1153) | 250 µg | inquiry |
| ACPP-1302 | Noelin Blocking Peptide (AC1302) | 250 µg | inquiry |
| ACPP-1257 | MC4 Receptor Blocking Peptide (AC1257) | 250 µg | inquiry |
| ACPP-1278 | EAAT1 Blocking Peptide (AC1278) | 250 µg | inquiry |
| ACPP-1702 | Human PCSK1N Protein (AC1702) | 2 µg | inquiry |
| ACPP-1334 | DRP1 Blocking Peptide (AC1334) | 250 µg | inquiry |
| ACPP-1101 | Recombinant Human SIRP alpha Protein (Fc Tag) (AC1101) | 50 µg | inquiry |
| ACPP-1655 | Human RAB23 Protein (AC1655) | 5 µg | inquiry |
| ACPP-1264 | SorLA Blocking Peptide (AC1264) | 250 µg | inquiry |
| ACPP-1420 | MOG (AC1420) | 5 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.